Presentation Information

[PO-085]DISSEMINATED HISTOPLASMOSIS AFTER USTEKINUMAB TREATMENT: SAFE, BUT IS IT THE SAFEST?

*SUKRIT SUD 1,2, GAURAV KHATANA1,2, LIPIKA LIPI4,3, Shanky Koul1,2, Monika Kallani4,6, RANDHIR SUD1,5, Smruti Ranjan Mishra1,7 (1. MD DM, 2. Consultant Gastroenterology- Medanta- The Medicity, Gurugram, 3. Associate director, Pathology-Medanta- The Medicity, Gurugram, 4. MD, 5. The Chairman, Institute of Digestive and Hepatobiliary Sciences, Medanta-The Medicity, Gurugram, 6. Resident, 7. Director, Institute of Digestive and Hepatobiliary Sciences, Medanta-The Medicity, Gurugram)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Comment

To browse or post comments, you must log in.Log in